It doesn't have the highest yield, but it has enviable dividend coverage and a long history of surviving in a competitive industry.
Pfizer Inc. is rated a Hold due to structural challenges despite recent 12% total return and compelling 6.7% dividend yield.
Pfizer Inc. (NYSE:PFE) is included among the 12 Best Dividend Stocks with Yields Above 4%. Pfizer Inc. (NYSE:PFE) is a major US pharmaceutical and biotechnology company that offers a wide range ...
Explore Pfizer Inc.’s 2025-2026 outlook: challenges, flat revenues, patent risks, and potential from the Metsera deal. Click ...
Pfizer's 7% dividend yield ranks among the highest in the healthcare sector, nearly triple the average of the S&P 500. The payout ratio has improved to 89% from over 100% in recent quarters, but ...
Pfizer (PFE) just laid out a 2026 outlook that underwhelmed the market, with lower expected earnings and revenue as COVID-19 ...
Pfizer and Bristol Myers Squibb are deeply out-of-favor drugmakers, but one could be the better turnaround candidate if you ...
The investment case for pharmaceutical giant Pfizer is presenting a complex puzzle. Conflicting signals are creating a stark ...
MarketBeat on MSN
Pfizer adds to its big bet on weight loss drugs
Health care stocks have been on a run lately, leading the S&P 500’s 11 sectors over the past three months with a gain of ...
Currently, Pfizer’s high yield cushions investors against tariff-related woes and rising consumer prices in the United States. Pfizer’s dividend yield is approximately 6.9%, and the company has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback